Publications<< Back

Escolar G, Diaz-Ricart M, Arellano-Rodrigo E, Galán AM

The pharmacokinetics of edoxaban for the prevention and treatment of venous thromboembolism.

Expert Opin Drug Metab Toxicol. 2014 Mar;10(3):445-58, PMID: 24471416

Thromboembolic diseases will become the most important contributors to mortality and morbidity for modern societies. Current antithrombotic strategies using heparins or vitamin K antagonists are inconvenient, with limitations and inherent side effects. A series of new oral anticoagulants with powerful and reliable antithrombotic actions have been developed in the last decade.


Download publication

An initiative of

Ministerio de Economía y Competitividad Fondo Europeo de Desarrollo Regional IMIM - Parc de Salut Mar